10-2-2814 US importer questionnaire

OMB No. 3117-0016/USITC No. 10-2-2814; Expiration Date: 6/30/2011
(No response is required if currently valid OMB control number is not displayed)

U.S. IMPORTERS’ QUESTIONNAIRE
CHLOROPICRIN FROM CHINA

This questionnaire must be received by the Commission by no later than DECEMBER 16, 2009
See page 4 of the Instruction Booklet for filing instructions.
The information called for in this questionnaire is for use by the United States International Trade Commission in
connection with its review of the antidumping duty order concerning chloropicrin from China (inv. No. 731-TA-130
(Third Review)). The information requested in the questionnaire is requested under the authority of the Tariff Act of
1930, title VII. This report is mandatory and failure to reply as directed can result in a subpoena or other order to
compel the submission of records or information in your possession (19 U.S.C. § 1333(a)).

Name of firm
Address
State

City

Zip Code

World Wide Web address
Has your firm imported chloropicrin (as defined in the instruction booklet) from any country at any time since
January 1, 2006?

NO
YES

(Sign the certification below and promptly return only this page of the questionnaire to the Commission)
(Read the instruction booklet carefully, complete all parts of the questionnaire, and return the entire
questionnaire to the Commission so as to be received by the date indicated above)

CERTIFICATION
I certify that the information herein supplied in response to this questionnaire is complete and correct to the best of my knowledge
and belief and understand that the information submitted is subject to audit and verification by the Commission.
By means of this certification I also grant consent for the Commission, and its employees and contract personnel, to use the
information provided in this questionnaire and throughout this review in any other import-injury investigations or reviews
conducted by the Commission on the same or similar merchandise.
I acknowledge that information submitted in this questionnaire response and throughout this review may be used by the
Commission, its employees, and contract personnel who are acting in the capacity of Commission employees, for developing or
maintaining the records of this review or related proceedings for which this information is submitted, or in internal audits and
investigations relating to the programs and operations of the Commission pursuant to 5 U.S.C. Appendix 3. I understand that all
contract personnel will sign non-disclosure agreements.

Name of Authorized Official

Title of Authorized Official
Phone: (

Date

)

Signature

E-mail address
Fax (

)

Business Proprietary
U.S. Importers’ Questionnaire – Chloropicrin from China (731-TA-130 (Third Review))

Page 2

PART I.—GENERAL INFORMATION
The questions in this questionnaire have been reviewed with market participants to ensure that issues of
concern are adequately addressed and that data requests are sufficient, meaningful, and as limited as
possible. Public reporting burden for this questionnaire is estimated to average 40 hours per response,
including the time for reviewing instructions, searching existing data sources, gathering the data needed,
and completing and reviewing the questionnaire. Send comments regarding the accuracy of this burden
estimate or any other aspect of this collection of information, including suggestions for reducing the
burden, to the Office of Investigations, U.S. International Trade Commission, 500 E Street, SW,
Washington, DC 20436.
I-1a.

OMB statistics.--Please report below the actual number of hours required and the cost to your
firm of preparing the reply to this questionnaire and completing the form.
hours

dollars

I-1b.

OMB feedback.--We are interested in any comments you may have for improving this
questionnaire in general or the clarity of specific questions. Please attach such comments to your
response or send them to the above address.

I-2.

Establishments covered.--Provide the name and address of establishment(s) covered by this
questionnaire (see page 3 of the instruction booklet for reporting guidelines). If your firm is
publicly traded, please specify the stock exchange and trading symbol.

I-3.

Ownership.--Is your firm owned, in whole or in part, by any other firm?
No

Yes--List the following information.

Firm name

Address

Extent of
ownership

Business Proprietary
U.S. Importers’ Questionnaire - Chloropicrin from China (731-TA-130 (Third Review))

Page 3

PART I.--GENERAL INFORMATION--Continued
I-4.

I-5.

Related SUBJECT importers/exporters.--Does your firm have any related firms, either
domestic or foreign, which are engaged in importing chloropicrin from China into the United
States or which are engaged in exporting chloropicrin from China to the United States?
No

Yes--List the following information.

Firm name

Address

Related NONSUBJECT importers/exporters.--Does your firm have any related firms, either
domestic or foreign, which are engaged in importing chloropicrin from countries other than China
into the United States or which are engaged in exporting chloropicrin from countries other than
China to the United States?
No

Yes--List the following information.

Firm name and country

I-6.

I-7.

Affiliation

Address

Affiliation

Related producers.--Does your firm have any related firms, either domestic or foreign, which
are engaged in the production of chloropicrin?
No

Yes--List the following information.

Firm name

Address

Affiliation

Nature of import operations.--Please indicate the nature of your firm’s importing operations on
chloropicrin. More than one answer may be applicable.
Importer of record

Takes title to the imported product(s)

Consignee of the imported products(s)

Customs broker or freight forwarder

Business Proprietary
U.S. Importers’ Questionnaire - Chloropicrin from China (731-TA-130 (Third Review))

Page 4

PART I.--GENERAL INFORMATION--Continued
I-8.

Consignees.--If your firm is an importer of record of chloropicrin but is not the consignee, please
list the consignees below (firm name, address, telephone number, and individual to contact).

Firm name

I-9.

I-10.

FTZs or bonded warehouse.--Please indicate whether your firm enters chloropicrin into, or
withdraws such merchandise from, foreign trade zones or bonded warehouses.
Foreign trade zones

No

Yes

Bonded warehouses

No

Yes

TIB.--Please indicate whether your firm imports chloropicrin under the TIB (temporary
importation under bond) program.
No

I-11.

Yes

Business plan.--In Parts II and III of this questionnaire we request a copy of your company’s
business plan. Does your company or any related firm have a business plan or any internal
documents that describe, discuss, or analyze expected market conditions for chloropicrin?
No

I-12.

Contact person and phone
number

Address

Yes–Please provide the requested documents. If you are not providing the
requested documents, please explain why not.

Other investigations.--To your knowledge, have the products subject to this proceeding been the
subject of any other import relief investigations in the United States or in any other countries?
No

Yes–Please specify.

Business Proprietary
U.S. Importers’ Questionnaire - Chloropicrin from China (731-TA-130 (Third Review))

Page 5

PART II.--TRADE AND RELATED INFORMATION
Further information on this part of the questionnaire can be obtained from Cynthia Trainor (202-2053354, cynthia.trainor@usitc.gov). Supply all data requested on a calendar-year basis.
II-1.

Contact information (Trade).--Who should be contacted regarding the requested trade and
related information?
Company contact:
Name and title
(
)
Phone number

II-2.

E-mail address

Changes in operations.--Please indicate whether your firm has experienced any of the following
changes in relation to the importation of chloropicrin since January 1, 2006?
(check as many as appropriate)
office/warehouse openings .......

office/warehouse closings ........

relocations ................................

expansions ................................

acquisitions...............................

consolidations...........................

prolonged shutdowns or
importation curtailments ................
revised labor agreements ..........

other..........................................

(please describe)

Business Proprietary
U.S. Importers’ Questionnaire - Chloropicrin from China (731-TA-130 (Third Review))

Page 6

PART II.--TRADE AND RELATED INFORMATION--Continued

II-3.

Anticipated changes in operations.--Does your firm anticipate any changes in the character of
your operations or organization (as noted above) relating to the importation of chloropicrin in the
future?
No

Yes–Supply details as to the time, nature, and significance of such changes
and provide underlying assumptions, along with relevant portions of
business plans or other supporting documentation that address this
issue.

II-4.
Anticipated changes in operations in the event the order is revoked.--Would your
firm anticipate any changes in the character of your operations or organization (as noted above)
relating to the importation of chloropicrin in the future if the antidumping duty order on chloropicrin
from China were to be revoked?
No

II-5.

Arranged imports.--Has your firm imported or arranged for the importation of chloropicrin from
China for delivery after September 30, 2009?
No

II-6.

Yes–Supply details as to the time, nature, and significance of such changes
and provide underlying assumptions, along with relevant portions of
business plans or other supporting documentation that address this
issue.

Yes--Indicate when such orders are to be delivered and the quantities
involved.

Reasons for importing if producer.--If your firm also produces chloropicrin in the United
States, please indicate your reasons for importing this product. If your reasons differ by source,
please elaborate.

Business Proprietary
U.S. Importers’ Questionnaire - Chloropicrin from China (731-TA-130 (Third Review))

Page 7

PART II.--TRADE AND RELATED INFORMATION--Continued
II-7a.

Imports from China.--Does your firm import chloropicrin from China?
No.

Yes-- Report your firm’s imports and your firm’s shipments and inventories
of chloropicrin imported from China by your firm during the
specified periods. (See definitions in the instruction booklet.)

CHINA
Quantity (in 1,000 pounds), value (in $1,000)
Calendar year
Item

2006

2007

January-September
2008

2008

2009

Beginning-of-period
inventories (quantity) (A)
Imports:
Quantity (B)
Value (C)
U.S. shipments:
Commercial shipments:
Quantity (D)
Value (E)
Internal consumption/company transfers:
Quantity (F)
Value1 (G)
Export shipments:2
Quantity (H)
Value (I)
End-of-period inventories
(quantity) (J)
Channels of distribution:
U.S. shipments to
distributors (quantity) (K)
U.S. shipments to end users
(quantity) (L)
1

Sales to related firms (including internal consumption) must be valued at fair market value. In the event that you use
a different basis for valuing these sales within your company, please specify that basis (e.g., cost, cost plus, etc.) and
provide value data using that basis for each period identified above:
2

Identify your principal export markets:

Business Proprietary
U.S. Importers’ Questionnaire - Chloropicrin from China (731-TA-130 (Third Review))

Page 8

PART II.--TRADE AND RELATED INFORMATION--Continued
II-7b.

Imports from ALL OTHER SOURCES.--Does your firm import chloropicrin from countries
other than China?
No.

Yes-- Report your firm’s imports and your firm’s shipments and inventories
of chloropicrin imported from countries other than China by your
firm during the specified periods. (See definitions in the instruction
booklet.)

ALL OTHER SOURCES COMBINED
Quantity (in 1,000 pounds), value (in $1,000)
Calendar year
Item

2006

2007

January-September
2008

2008

2009

Beginning-of-period
inventories (quantity) (A)
Imports:
Quantity (B)
Value (C)
U.S. shipments:
Commercial shipments:
Quantity (D)
Value (E)
Internal consumption/company transfers:
Quantity (F)
Value1 (G)
Export shipments:2
Quantity (H)
Value (I)
End-of-period inventories
(quantity) (J)
Channels of distribution:
U.S. shipments to
distributors (quantity) (K)
U.S. shipments to end users
(quantity) (L)
1

Sales to related firms (including internal consumption) must be valued at fair market value. In the event that you use a
different basis for valuing these sales within your company, please specify that basis (e.g., cost, cost plus, etc.) and provide value
data using that basis for each period identified above:
2

Identify your principal export markets:

Business Proprietary
U.S. Importers’ Questionnaire - Chloropicrin from China (731-TA-130 (Third Review))

Page 9

PART II.--TRADE AND RELATED INFORMATION--Continued
II-8.

Reconciliation of import data.-(a)

Please note that the quantities reported in question II-7 should reconcile as follows in
each period (i.e., in each column):
Reconciliation
A+B–D–F–H=J
D+F=K+L

(b)

Yes

No--(Please
)

Yes

No--( Please

Please note that the quantities reported for end-of-period inventories should equal the
beginning-of-period inventories reported in the subsequent calendar year (i.e., line J of
year 2006 should equal line B of year 2007). Do these data reconcile for each adjacent
calendar year?
Yes.

II-9.

Do these data reconcile?
explain:
Do these data reconcile?
explain:

No--Please explain.

Effect of order.--Describe the significance of the existing antidumping duty order covering
imports of chloropicrin from China in terms of its effect on your firm’s imports, U.S. shipments
of imports, and inventories. You may wish to compare your firm’s operations before and after
the imposition of the order.

)

Business Proprietary
U.S. Importers’ Questionnaire - Chloropicrin from China (731-TA-130 (Third Review))

Page 10

PART II.--TRADE AND RELATED INFORMATION--Continued
II-10.

Likely effect of revocation of order.--Would your firm anticipate any changes in its imports,
U.S. shipments of imports, or inventories of chloropicrin in the future if the antidumping duty
order on chloropicrin from China were to be revoked?
No

Yes–Supply details as to the time, nature, and significance of such changes
and provide underlying assumptions, along with relevant portions of
business plans or other supporting documentation for any trends or
projections you may provide.

Business Proprietary
U.S. Importers’ Questionnaire - Chloropicrin from China (731-TA-130 (Third Review))

Page 11

PART III.--PRICING AND MARKET FACTORS
Further information on this part of the questionnaire can be obtained from Joshua Levy (202-205-3236,
joshua.levy@usitc.gov)
III-1.

Contact information (Price).--Who should be contacted regarding the requested pricing and
related information?
Company contact:
Name and title
(
)
Phone number

E-mail address

PRICE DATA
This section requests quarterly price and quantity data, f.o.b. your U.S. point of shipment, for your
commercial shipments to unrelated U.S. customers since 2006 of the following products you imported
from China:
Product 1.—Chloropicrin (100 to 96 percent pure) sold in a 180,000 pound rail car
container (base quantities on 100 percent equivalent)
Product 2.-- Chloropicrin (100 to 96 percent pure) sold in a 50,000 pound ISO container
(base quantities on 100 percent equivalent)
Please note that total dollar values should be f.o.b., U.S. point of shipment and should not include
U.S.-inland transportation costs. Total dollar values should reflect the final net amount paid to you
(i.e., should be net of all deductions for discounts or rebates). See instruction booklet.

Business Proprietary
U.S. Importers’ Questionnaire - Chloropicrin from China (731-TA-130 (Third Review))

Page 12

PART III.--PRICING AND MARKET FACTORS--Continued
III-2.

Price data (China).--Report below the quarterly price data1 for pricing products2 imported from
China and sold by your firm.

CHINA
(Quantity in pounds of chloropicrin, value in dollars)
Product 1
Product 2
Period of shipment
Quantity
Value
Quantity
Value
2006:
January-March
April-June
July-September
October-December
2007:
January-March
April-June
July-September
October-December
2008:
January-March
April-June
July-September
October-December
2009:
January-March
April-June
July-September
1
Net values (i.e., gross sales values less all discounts, allowances, rebates, prepaid freight, and the value of
returned goods), f.o.b. your U.S. point of shipment.
2
Pricing product definitions are provided on the first page of Part III.
Note.--If your product does not exactly meet the product specifications but is competitive with the specified product,
provide a description of your product:
Product 1:
Product 2:

Business Proprietary
U.S. Importers’ Questionnaire - Chloropicrin from China (731-TA-130 (Third Review))

Page 13

PART III.--PRICING AND MARKET FACTORS--Continued
III-3. Price setting.-- How does your firm determine the prices that it charges for sales of
chloropicrin (check all that apply)? If your firm issues price lists, please include a copy of a
recent price list with your submission. If your price list is large, please only submit some sample
pages.
Transaction by transaction

Contracts

Set price lists

Other--Please describe:

III-4.

Discount policy.-- Please indicate and describe your firm’s discount policies (check all that
apply).
Quantity discounts

Annual total volume discounts

No discount policy

Other--Please describe:

III-5.

III-6.

Pricing terms for Chloropicrin.-(a)

What are your firm’s typical sales terms for its imported chloropicrin (e.g., 2/10 net 30
days)?
.

(b)

On what basis are your prices of imported chloropicrin usually quoted? (check one)
F.o.b.--Please specify point:
Delivered

Contract versus spot.--Approximately what share of your firm’s sales of its imported
chloropicrin in 2008 were on a (1) long-term contract basis (multiple deliveries for more than 12
months), (2) short-term contract basis (multiple deliveries up to and including 12 months), and (3)
spot sales basis (for a single delivery)?
Type of sale
Long-term contracts
Short-term contracts
Spot sales

Share of sales (percent)

Business Proprietary
U.S. Importers’ Questionnaire - Chloropicrin from China (731-TA-130 (Third Review))

Page 14

PART III.--PRICING AND MARKET FACTORS--Continued
III-7.

III-8.

III-9.

Long-term contact provisions.--If you sell on a long-term contract basis, please answer the
following questions with respect to provisions of a typical long-term contract.
(a)

What is the average duration of a contract?

(b)

Can prices be renegotiated during the contract period?

(c)

Does the contract fix quantity, price, or both?

(d)

Does the contract have a meet or release provision?

Yes

Quantity

No
Price

Yes

Both
No

Short-term contract provisions.--If you sell on a short-term contract basis, please answer the
following questions with respect to provisions of a typical short-term contract.
(a)

What is the average duration of a contract?

(b)

Can prices be renegotiated during the contract period?

(c)

Does the contract fix quantity, price, or both?

(d)

Does the contract have a meet or release provision?

Yes

Quantity

No
Price

Yes

Both
No

Lead times.--What is the average lead time between a customer’s order and the date of delivery
for your firm’s sales of chloropicrin?

Source

Share of sales,
2008

Lead time

From your firm’s inventory
From foreign manufacturers’
inventory
Produced to order
Total

100 %

III-10. Shipping information.-(a)

What is the approximate percentage of the total delivered cost of chloropicrin that is
accounted for by U.S. inland transportation costs?
percent.

(b)

Who generally arranges the transportation to your customers’ locations? (check one)
Your firm
or purchaser

(c)

What proportion of your sales are delivered within 100 miles of your point of importation
( ) or storage facility ( ) (check one, then provide the percentages)?
percent.
Within 101 to 1,000 miles?
percent. Over 1,000 miles?
percent. Be sure to
check one of the two options for measurement.

Business Proprietary
U.S. Importers’ Questionnaire - Chloropicrin from China (731-TA-130 (Third Review))

Page 15

PART III.--PRICING AND MARKET FACTORS--Continued
III-11. Geographical shipments.--Based on the quantity of your firm’s U.S. shipments in 2008 as
reported in response to questions II-7 above, please indicate the percentage share for which each
of the following geographic markets account. Please answer this question in reference to your
sales to ultimate delivery destinations to customers in the United States.
Share of U.S. shipments in 2008
(in percent)
Of imports
from
China

Geographic area

Of imports from
ALL OTHER
SOURCES

Northeast.–CT, ME, MA, NH, NJ, NY, PA, RI, and VT.
Midwest.–IL, IN, IA, KS, MI, MN, MO, NE, ND, OH, SD, and WI.
Southeast.–AL, DE, DC, FL, GA, KY, MD, MS, NC, SC, TN, VA,
and WV.
Central Southwest.–AR, LA, OK, and TX.
Mountains.–AZ, CO, ID, MT, NV, NM, UT, and WY.
Pacific Coast.–CA, OR, and WA.
Other.–All other markets in the United States not previously listed,
including AK, HI, PR, VI, among others.
Note.--These shares should be calculated from all reported U.S. shipments in 2008 (lines D and F) from question II-7.

III-12. End uses.--Describe the end uses of the chloropicrin that you import from China. For each enduse product, what percentage of the total cost is accounted for by chloropicrin?
Share of total cost of end
product (percent)

End use

III-13. Changes in end uses.--Have there been any changes in the end uses of chloropicrin since 2006?
No

Yes--Please describe.

Business Proprietary
U.S. Importers’ Questionnaire - Chloropicrin from China (731-TA-130 (Third Review))

Page 16

PART III.--PRICING AND MARKET FACTORS--Continued
III-14. Anticipated changes in end uses.--Do you anticipate any changes in terms of the end uses of
chloropicrin in the future?
No

Yes--Please describe and identify the time period. Provide any underlying
assumptions, along with relevant portions of business plans or other
supporting documentation that address this issue.

III-15. Substitutes.--Please list in order of importance any products that may be substituted for
chloropicrin. For each possible substitute product, please give examples of applications and end
uses for which they are substitutes and indicate whether changes in the price of the substitute
affect the price for chloropicrin, and to what degree, and the length of any time lag of such an
effect.

Substitute

Description

Have changes in the prices of this
substitute affected the price for
chloropicrin?

1.

No

Yes--Please explain.

2.

No

Yes--Please explain.

3.

No

Yes--Please explain.

4.

No

Yes--Please explain.

5.

No

Yes--Please explain.

Business Proprietary
U.S. Importers’ Questionnaire - Chloropicrin from China (731-TA-130 (Third Review))

Page 17

PART III.--PRICING AND MARKET FACTORS--Continued
III-16. Changes in substitutes.--Have there been any changes in the number or types of products that
can be substituted for chloropicrin since 2006?
No

Yes--Please explain.

III-17. Anticipated changes in substitute.--Do you anticipate any changes in terms of the
substitutability of other products for chloropicrin in the future?
No

Yes--Please describe and provide any underlying assumptions, along with
relevant portions of business plans or other supporting documentation
that address this issue.

III-18. Raw materials.--To what extent have changes in the prices of raw materials affected your firm’s
selling prices for chloropicrin since 2006? Also discuss any anticipated changes in your raw
material costs in the future, identifying the time period(s) involved and the factor(s) that you
believe would be responsible for such changes. Provide any underlying assumptions, along with
relevant portions of business plans or other supporting documentation that address this issue.

III-19. Changes in factors affecting supply.--Have any changes occurred in any other factors affecting
supply (e.g., changes in availability or prices of energy or labor; transportation conditions;
production capacity and/or methods of production; technology; export markets; or alternative
production opportunities) that affected the availability of U.S.-produced chloropicrin in the U.S.
market since 2006?
No

Yes--Please note the time period(s) of any such changes, the factors(s)
involved, and the impact such changes had on your shipment volumes
and prices.

Business Proprietary
U.S. Importers’ Questionnaire - Chloropicrin from China (731-TA-130 (Third Review))

Page 18

PART III.--PRICING AND MARKET FACTORS--Continued
III-20. Changes in regulations.-(a)

Have any changes occurred in regulations that affect the availability of chloropicrin in the
U.S. market since 2006?
No

(b)

Yes--Please note the types of regulations, the timing of the changes in
regulations, and the impact of these regulations on your shipment
volumes and prices.

Have any changes occurred in regulations that affect the demand for chloropicrin in the
U.S. market since 2006?
No

Yes-- Please note the types of regulations, the timing of the changes
in regulations, and the impact of these regulations on your shipment
volumes and prices.

III-21. Availability of “subject” import supply.-(a)

Do you anticipate any changes in terms of the availability of chloropicrin imported from
China in the U.S. market in the future?
Increase

(b)

No change

Decrease

If you anticipate changes in supply, please identify the changes, including the time period
and the impact of such changes on shipment volumes and prices. Provide any underlying
assumptions, along with relevant portions of business plans or other supporting
documentation that address this issue.

III-22. Availability of “nonsubject” import supply.--Has the availability of NONSUBJECT
chloropicrin (i.e., chloropicrin imported from countries other than China) changed since 2006?
No

Yes--Please explain.

Business Proprietary
U.S. Importers’ Questionnaire - Chloropicrin from China (731-TA-130 (Third Review))

Page 19

PART III.--PRICING AND MARKET FACTORS--Continued
III-23. Export constraints.--Describe how easily your firm can shift its sales of chloropicrin between
the U.S. market and alternative country markets. In your discussion, please describe any
contracts, other sales arrangements, or other constraints that would prevent or retard your firm
from shifting chloropicrin between the U.S. and alternative country markets within a 12-month
period. Provide any underlying assumptions, along with relevant portions of business plans or
other supporting documentation that address this issue.

III-24. Product changes.--Have there been any significant changes in the product range, product mix, or
marketing (including sales over the internet) of chloropicrin since 2006?
No

Yes--Please describe and quantify if possible.

III-25. Anticipated product changes.--Do you anticipate any changes in terms of the product range,
product mix, or marketing (including sales over the internet) of chloropicrin in the future?
Provide any underlying assumptions, along with relevant portions of business plans or other
supporting documentation that address this issue.
No

Yes--Please identify, including the time period.

III-26. Demand trends.-(a)

How has the demand within the United States for chloropicrin changed since January 1,
2006? What principal factors affect changes in demand?
Increased

No Change

Decreased

Fluctuated

Business Proprietary
U.S. Importers’ Questionnaire - Chloropicrin from China (731-TA-130 (Third Review))

Page 20

PART III.--PRICING AND MARKET FACTORS--Continued
(b)

How has the demand outside the United States (if known) for chloropicrin changed since
January 1, 2006? What principal factors affect changes in demand?
Increased

No Change

Decreased

Fluctuated

III-27. Anticipated demand trends.-(a)

How do you anticipate demand will change within the United States for chloropicrin in
the future? What principal factors that will affect these changes in demand?
Increase

(b)

No Change

Decrease

Fluctuate

How do you anticipate demand will change outside the United States for chloropicrin to
in the future? What principal factors that will affect these changes in demand?
Increase

No Change

Decrease

Fluctuate

III-28. Price comparisons.--Please compare market prices of chloropicrin in U.S. and non-U.S. markets,
if known. Provide specific information as to time periods and regions for any price comparisons.

III-29. Market studies.--Please provide as a separate attachment to this request any studies, surveys, etc.
that you are aware of that quantify and/or otherwise discuss chloropicrin supply (including
production capacity and capacity utilization) and demand in (1) the United States, (2) each of the
other major producing/consuming countries, including China, and (3) the world as a whole. Of
particular interest is such data from 2006 to the present and forecasts for the future.

Business Proprietary
U.S. Importers’ Questionnaire - Chloropicrin from China (731-TA-130 (Third Review))

Page 21

PART III.--PRICING AND MARKET FACTORS--Continued
III-30. Interchangeability by country-pair.--Is chloropicrin produced in the United States and in other
countries interchangeable (i.e., can they physically be used in the same applications)? Please
indicate below, using “A” to indicate that the products from a specified country-pair are always
interchangeable, “F” to indicate that the products are frequently interchangeable, “S” to indicate
that the products are sometimes interchangeable, “N” to indicate that the products are never
interchangeable, and “0” to indicate no familiarity with products from a specified country-pair.1
Country-pair

China

Other countries

United States
China
1

For any country-pair producing chloropicrin which is sometimes or never interchangeable, please
explain the factors that limit or preclude interchangeable use:

Business Proprietary
U.S. Importers’ Questionnaire - Chloropicrin from China (731-TA-130 (Third Review))

Page 22

PART III.--PRICING AND MARKET FACTORS--Continued
III-31. Differences other than price by country-pair.--Are differences other than price (i.e., quality,
availability, transportation network, product range, technical support, etc.) between chloropicrin
produced in the United States and in other countries a significant factor in your firm’s sales of the
products? Please indicate below, using “A” to indicate that such differences are always
significant, “F” to indicate that such differences are frequently significant, “S” to indicate that
such differences are sometimes significant, “N” to indicate that such differences are never
significant, and “0” to indicate no familiarity with products from a specified country-pair.1
Country-pair

China

Other countries

United States
China
1

For any country-pair for which factors other than price always or frequently are a significant factor in your firm’s
sales of chloropicrin, identify the country-pair and report the advantages or disadvantages imparted by such
factors: